Suppr超能文献

韩国大型队列中白质高信号的性别特异性风险因素及临床痴呆症结局

Sex-Specific Risk Factors and Clinical Dementia Outcomes for White Matter Hyperintensities in a large South Korean Cohort.

作者信息

Schweitzer Noah, Son Sang Joon, Thurston Rebecca C, Li Jinghang, Chen Chang-Le, Aizenstein Howard, Yang Shaolin, Iordanova Bistra, Hong Chang Hyung, Roh Hyun Woong, Cho Yong Hyuk, Hong Sunhwa, Nam You Jin, Lee Dong Yun, Park Bumhee, Kim Na-Rae, Choi Jin Wook, Cheong Jaeyoun, Seo Sang Woon, An Young-Sil, Moon So Young, Han Seung Jin, Wu Minjie

机构信息

University of Pittsburgh.

Ajou University School of Medicine.

出版信息

Res Sq. 2024 Jun 12:rs.3.rs-4473148. doi: 10.21203/rs.3.rs-4473148/v1.

Abstract

OBJECTIVE

White matter hyperintensities (WMH) on brain MRI images are the most common feature of cerebral small vessel disease (CSVD). Studies have yielded divergent findings on the modifiable risk factors for WMH and WMH's impact on cognitive decline. Mounting evidence suggests sex differences in WMH burden and subsequent effects on cognition. Thus, we aimed to identify sex-specific modifiable risk factors for WMH. We then explored whether there were sex-specific associations of WMH to longitudinal clinical dementia outcomes.

METHODS

Participants aged 49-89 years were recruited at memory clinics and underwent a T2-weighted fluid-attenuated inversion recovery (FLAIR) 3T MRI scan to measure WMH volume. Participants were then recruited for two additional follow-up visits, 1-2 years apart, where clinical dementia rating sum of boxes (CDR-SB) scores were measured. We first explored which known modifiable risk factors for WMH were significant when tested for a sex-interaction effect. We additionally tested which risk factors were significant when stratified by sex. We then tested to see whether WMH is longitudinally associated with clinical dementia that is sex-specific.

RESULTS

The study utilized data from 713 participants (241 males, 472 females) with a mean age of 72.3 years and 72.8 years for males and females, respectively. 57.3% and 59.5% of participants were diagnosed with mild cognitive impairment (MCI) for males and females, respectively. 40.7% and 39.4% were diagnosed with dementia for males and females, respectively. Of the 713 participants, 181 participants had CDR-SB scores available for three longitudinal time points. Compared to males, females showed stronger association of age to WMH volume. Type 2 Diabetes was associated with greater WMH burden in females but not males. Finally, baseline WMH burden was associated with worse clinical dementia outcomes longitudinally in females but not in males.

DISCUSSION

Elderly females have an accelerated increase in cerebrovascular burden as they age, and subsequently are more vulnerable to clinical dementia decline due to CSVD. Additionally, females are more susceptible to the cerebrovascular consequences of diabetes. These findings emphasize the importance of considering sex when examining the consequences of CSVD. Future research should explore the underlying mechanisms driving these sex differences and personalized prevention and treatment strategies.

CLINICAL TRIAL REGISTRATION

The BICWALZS is registered in the Korean National Clinical Trial Registry (Clinical Research Information Service; identifier, KCT0003391). Registration Date 2018/12/14.

摘要

目的

脑磁共振成像(MRI)图像上的白质高信号(WMH)是脑小血管疾病(CSVD)最常见的特征。关于WMH的可改变风险因素以及WMH对认知衰退的影响,研究结果存在分歧。越来越多的证据表明,WMH负担及其对认知的后续影响存在性别差异。因此,我们旨在确定WMH的性别特异性可改变风险因素。然后,我们探讨了WMH与纵向临床痴呆结局之间是否存在性别特异性关联。

方法

在记忆诊所招募了年龄在49 - 89岁之间的参与者,并进行了3T T2加权液体衰减反转恢复(FLAIR)MRI扫描以测量WMH体积。然后,参与者被招募进行另外两次随访,间隔1 - 2年,测量临床痴呆评定量表框和(CDR - SB)分数。我们首先探讨了在测试性别交互效应时,哪些已知的WMH可改变风险因素是显著的。我们还分别按性别分层测试了哪些风险因素是显著的。然后,我们测试了WMH是否与性别特异性的纵向临床痴呆相关。

结果

该研究使用了713名参与者(241名男性,472名女性)的数据,男性和女性的平均年龄分别为72.3岁和72.8岁。男性和女性参与者中分别有57.3%和59.5%被诊断为轻度认知障碍(MCI)。男性和女性分别有40.7%和39.4%被诊断为痴呆。在713名参与者中,有181名参与者在三个纵向时间点有CDR - SB分数。与男性相比,女性的年龄与WMH体积的关联更强。2型糖尿病与女性而非男性的WMH负担加重有关。最后,基线WMH负担在女性中与纵向更差的临床痴呆结局相关,而在男性中则不然。

讨论

老年女性随着年龄增长脑血管负担加速增加,随后由于CSVD更容易出现临床痴呆衰退。此外,女性更容易受到糖尿病的脑血管后果影响。这些发现强调了在研究CSVD后果时考虑性别的重要性。未来的研究应该探索驱动这些性别差异的潜在机制以及个性化的预防和治疗策略。

临床试验注册

BICWALZS已在韩国国家临床试验注册中心(临床研究信息服务;标识符,KCT0003391)注册。注册日期2018/12/14。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7cf/11213210/2864b8e932d1/nihpp-rs4473148v1-f0001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验